Please assess the completion status of the following clinical trial:

Trial Title: Zilver PTX Delivery System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has symptomatic vascular disease of the native above-the-knee femoropopliteal arteries~* Patient has atherosclerotic lesion of the above-the-knee femoropopliteal artery~Exclusion Criteria:~* Patient is \< 18 years of age~* Patient unable to complete required follow-up assessments~* Patient unwilling to sign and date the informed consent~* Simultaneous participation in another investigational drug or device study~* Pregnant, breastfeeding or planning to become pregnant in the next 5 years~* Additional medical/anatomical restrictions as specified in the Clinical Investigation Plan

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Drug Eluting Stent (Type: EXPERIMENTAL): Zilver® Paclitaxel(PTX)® Drug-Eluting Peripheral Stent

Based on this trial design, predict the completion outcome and termination type (if applicable).